ES2149985T3 - Derivados imidazolilalquilo de imidazo(1,5-a)indol-3-ona y su uso como agentes terapeuticos. - Google Patents

Derivados imidazolilalquilo de imidazo(1,5-a)indol-3-ona y su uso como agentes terapeuticos.

Info

Publication number
ES2149985T3
ES2149985T3 ES95917985T ES95917985T ES2149985T3 ES 2149985 T3 ES2149985 T3 ES 2149985T3 ES 95917985 T ES95917985 T ES 95917985T ES 95917985 T ES95917985 T ES 95917985T ES 2149985 T3 ES2149985 T3 ES 2149985T3
Authority
ES
Spain
Prior art keywords
sub
hydrogen
imidazolylalkyl
ona
imidazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95917985T
Other languages
English (en)
Inventor
Mario Varasi
Franco Heidempergher
Carla Caccia
Patricia Salvati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Application granted granted Critical
Publication of ES2149985T3 publication Critical patent/ES2149985T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

COMPUESOS ANTAGONISTAS RECEPTORES 5-HT 3 NOVEDOSOS DE FORMULA (I) DONDE N ES 1,2 O 3; CADA UNO DE R,R{SUB,1} Y R{SUB,2}, QUE PUEDEN SER IGUALES O DISTINTOS, ES HIDROGENO, HALOGENO, HIDROXI, CIANO, C{SUB,1}-C{SUB,6}ALQUIL, CF{SUB,3}, C{SUB,1}-C{SUB,6}ALCOXI, C{SUB,1}-C{SUB,6}ALQUITIO, FORMIL, C{SUB,2}-C{SUB,6}ALCANOIL, CARBOXI, C{SUB,1}-C{SUB,6}ALCOXICARBONIL, NITRO, -N (R{SUB,4}R{SUB,5}) EN EL QUE CADA R{SUB,4} Y R{SUB,5} SON INDEPENDIENTEMENTE HIDROGENO, C{SUB,1}C{SUB,6}ALQUIL, FORMIL O C{SUB,2}-C{SUB,6}ALCANOIL; O UN GRUPO (R{SUB,6}R{SUB,7}) N-SO{SUB,2}, EN EL QUE CADA R{SUB,6} Y R{SUB,7} SON INDEPENDIENTEMENTE HIDROGENO O C{SUB,1}C{SUB,6}ALQUIL; R{SUB,3} ES UN GRUPO IMIDAZOLIL DE FORMULA (A) O (B), DONDE CADA R{SUB,8} Y R{SUB,10} QUE PUEDEN SER IGUALES O DISTINTAS, ES HIDROGENO, O C{SUB,1}-C{SUB,6}ALQUIL, R{SUB,9} ES HIDROGENO, C{SUB,1}-C{SUB,6}ALQUIL O UN GRUPO PROTECTOR DE NITROGENO; Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS.
ES95917985T 1994-05-25 1995-05-02 Derivados imidazolilalquilo de imidazo(1,5-a)indol-3-ona y su uso como agentes terapeuticos. Expired - Lifetime ES2149985T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9410456A GB9410456D0 (en) 1994-05-25 1994-05-25 Imidazolylalkyl derivatives of imidazo (1,5-a) and process for their preparati

Publications (1)

Publication Number Publication Date
ES2149985T3 true ES2149985T3 (es) 2000-11-16

Family

ID=10755680

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95917985T Expired - Lifetime ES2149985T3 (es) 1994-05-25 1995-05-02 Derivados imidazolilalquilo de imidazo(1,5-a)indol-3-ona y su uso como agentes terapeuticos.

Country Status (8)

Country Link
US (1) US5874457A (es)
EP (1) EP0711293B1 (es)
JP (1) JP3657986B2 (es)
CA (1) CA2166619A1 (es)
DE (1) DE69517767T2 (es)
ES (1) ES2149985T3 (es)
GB (1) GB9410456D0 (es)
WO (1) WO1995032204A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113583000A (zh) * 2021-07-09 2021-11-02 成都大学 一种制备咪唑并[1,5-a]吲哚-3-酮的方法
CN113582999A (zh) * 2021-07-09 2021-11-02 成都大学 一种制备咪唑并[1,5-a]吲哚化合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565902A (en) * 1967-09-15 1971-02-23 American Cyanamid Co 1,2-dihydro-3h-imidazo(1,5-a)indol-3-ones and 3-thiones

Also Published As

Publication number Publication date
DE69517767D1 (de) 2000-08-10
EP0711293A1 (en) 1996-05-15
DE69517767T2 (de) 2001-03-01
WO1995032204A1 (en) 1995-11-30
US5874457A (en) 1999-02-23
EP0711293B1 (en) 2000-07-05
JPH09500912A (ja) 1997-01-28
CA2166619A1 (en) 1995-11-30
JP3657986B2 (ja) 2005-06-08
GB9410456D0 (en) 1994-07-13

Similar Documents

Publication Publication Date Title
ES2132223T3 (es) Derivados de indol condensados en calidad de antagonistas del receptor 5-ht4.
DK0808318T3 (da) Tricykliske, substituerede hexahydrobenz[e]isoindol-alfa-1-adrenerge antagonister
ES2108700T3 (es) Derivados de diazabiciclonolilo como antagonistas del receptor 5-ht3.
ES2153907T3 (es) Compuestos espiro tetraciclicos, procedimiento para su preparacion y su uso como antagonistas del receptor 5ht1d.
ES2157366T3 (es) Derivados de pirimidindiona, pirimidintriona, triacindiona como antagonistas de receptores alfa-1-adrenergicos.
AR248013A1 (es) Compuesto de imidazol y composicion biocida que los contiene, excluidos sus usos medicinales y veterinarios, y el procedimiento de preparacion de los compuestos i y sus intermediarios.
ES2152317T3 (es) Derivados de arilideno y de heteroarilideno oxiindol utilizados como inhibidores de la tirosina quinasa.
BR0313942A (pt) Derivados de benzimidazol úteis como agentes antiproliferativos
ES2058342T3 (es) Pirroles, pirazoles y triazoles sustituidos antagonistas de la angiotensina ii.
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
AR003406A1 (es) Derivados de imidazol, procedimiento para su preparacion y preparaciones farmaceuticas que los contienen.
BG102820A (en) Substituted tetracyclic tetrahydrofurane derivatives
BG96180A (bg) Нови антихистаминови средства,производни на бензимидазолите
ES2183866T3 (es) Derivados de beta-aril y beta-heteroaril-alfa-cianoacrilamidas sustituido como inhibidors de la tirosina quinasa.
MX9806171A (es) Derivados 2,3-benzodiazepina y sus usos como inhibidores del receptor-ampa.
CY1106257T1 (el) ΧΡΗΣΗ ΠΑΡΑΓΩΓΩΝ ΠΥΡΙΔΑΖΙΝΟ [4,5-(b)]-ΙΝΔΟΛΗ -1-ΑΚΕΤΑΜΙΔΗ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΣΚΕΥΑΣΜΑΤΩΝ ΠΟΥ ΠΡΟΟΡΙΖΟΝΤΑΙ ΓΙΑ ΝΟΣΟΥΣ ΠΟΥ ΣΥΝΔΕΟΝΤΑΙ ΜΕ ΤΗ ΔΥΣΛΕΙΤΟΥΡΓΙΑ ΤΩΝ ΥΠΟΔΟΧΕΩΝ ΠEPΙΦEPΙΚΟΥ ΤΥΠΟΥ ΣΤΙΣ ΒΕΝΖΟΔΙΑΖΕΠΙΝΕΣ
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
ES2158861T3 (es) 4-imidometil-1-(2'-fenil-2'-oxoetil)-piperidinas como inhibidores de los receptores 5ht2 de la serotonina, su preparacion y sus aplicaciones terapeuticas.
ES2171911T3 (es) Poliaminas conformacionalmente restringidas y su uso como agentes antineoplasicos.
ES2164881T3 (es) Derivados de 6-carboxamido dihidropirano.
ES2160951T3 (es) Derivados de distamicina, procedimiento para la preparacion de los mismos y su uso como agentes antitumorales y antiviricos.
ES2149984T3 (es) Derivados imidazolilalquilos de imidazol(5,1-c)(1,4)benzoxazin-1-ona y su utilizacion como agentes terapeuticos.
MY131381A (en) Piperazine derivatives suitable for use as pharmaceuticals, in particular as 5-ht1a receptor binding agents.
ES2143630T3 (es) Derivados azabicicloalquilos de imidazo(1,5-a)indol-3-ona utilizados como antagonistas de 5ht3.
DK0942911T3 (da) Benzopyranopyrroler og benzopyranopyridiner med alfa-1-adrenerg virkning

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 711293

Country of ref document: ES